Back
BYD Vs. NovoCure Industry Stock Comparison
Buy
64
BYDDY
BYD
Last Price:
70.13
Seasonality Move:
5.34%
Buy
74
NVCR
NovoCure
Last Price:
31.11
Seasonality Move:
-5.24%
Buy
64
BYD (BYDDY)
is a Buy
Is BYD a Buy, Sell or Hold?
- The current BYD [BYDDY] share price is $70.14. The Score for BYDDY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- BYDDY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $29.72. The Score for NVCR is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BYDDY Stock Price Chart
BYDDY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 53.23 | Buy |
Chaikin Money Flow: | -100817 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.28 - 71.32) | Buy |
Bollinger Bands (100): | (58.39 - 72.77) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.28 | Buy |
Relative Strength Index (14 RSI): | 72.74 | Buy |
Chaikin Money Flow: | 874936 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.55 - 25.99) | Buy |
Bollinger Bands (100): | (15 - 21.7) | Buy |
BYDDY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.94 | Buy |
20-day SMA: | 67.87 | Buy |
50-day SMA: | 71.7 | Sell |
200-day SMA: | 60.51 | Buy |
8-day EMA: | 68.67 | Buy |
20-day EMA: | 68.67 | Buy |
50-day EMA: | 68.79 | Buy |
200-day EMA: | 63.09 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.82 | Buy |
20-day SMA: | 21.56 | Buy |
50-day SMA: | 18.36 | Buy |
200-day SMA: | 17.66 | Buy |
8-day EMA: | 27.05 | Buy |
20-day EMA: | 23.3 | Buy |
50-day EMA: | 20.08 | Buy |
200-day EMA: | 19.53 | Buy |
BYD Earnings Growth & BYDDY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
BYD Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |